Probi AB
STO:PROB

Watchlist Manager
Probi AB Logo
Probi AB
STO:PROB
Watchlist
Price: 350 SEK -0.28% Market Closed
Market Cap: 4B SEK
Have any thoughts about
Probi AB?
Write Note

P/OCF
Price to OCF

45.8
Current
26.1
Median
21.6
Industry
Higher than median
Higher than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
45.8
=
Market Cap
4B SEK
/
Operating Cash Flow
87.1m SEK
All Countries
Close
Market Cap P/OCF
SE
Probi AB
STO:PROB
4B SEK 45.8
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 316.7
US
Abbvie Inc
NYSE:ABBV
312.7B USD 18.9
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 21.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.2B USD -137.9
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 11.2
US
Epizyme Inc
F:EPE
94.1B EUR -470.1
AU
CSL Ltd
ASX:CSL
133.6B AUD 31.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.3B USD 19.1
US
Seagen Inc
F:SGT
39.3B EUR -75.9
NL
argenx SE
XBRU:ARGX
34.8B EUR -139.8
 
SE
Probi AB
STO:PROB
Average P/OCF: 24.7
45.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 316.7
US
Abbvie Inc
NYSE:ABBV
18.9
US
Amgen Inc
NASDAQ:AMGN
21.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -137.9
US
Gilead Sciences Inc
NASDAQ:GILD
11.2
US
E
Epizyme Inc
F:EPE
Negative Multiple: -470.1
AU
CSL Ltd
ASX:CSL
31.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -75.9
NL
argenx SE
XBRU:ARGX
Negative Multiple: -139.8

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More